These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21439944)

  • 21. Selenomethionine ameliorates cognitive decline, reduces tau hyperphosphorylation, and reverses synaptic deficit in the triple transgenic mouse model of Alzheimer's disease.
    Song G; Zhang Z; Wen L; Chen C; Shi Q; Zhang Y; Ni J; Liu Q
    J Alzheimers Dis; 2014; 41(1):85-99. PubMed ID: 24577479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.
    Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M
    Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progressive white matter pathology in the spinal cord of transgenic mice expressing mutant (P301L) human tau.
    Lin WL; Zehr C; Lewis J; Hutton M; Yen SH; Dickson DW
    J Neurocytol; 2005 Dec; 34(6):397-410. PubMed ID: 16902761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal evaluation of Tau-P301L transgenic mice reveals no cognitive impairments at 17 months of age.
    Kent BA; Heath CJ; Kim CH; Ahrens R; Fraser PE; St George-Hyslop P; Bussey TJ; Saksida LM
    Brain Behav; 2018 Jan; 8(1):e00896. PubMed ID: 29568692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apoptosis in oligodendrocytes is associated with axonal degeneration in P301L tau mice.
    Zehr C; Lewis J; McGowan E; Crook J; Lin WL; Godwin K; Knight J; Dickson DW; Hutton M
    Neurobiol Dis; 2004 Apr; 15(3):553-62. PubMed ID: 15056463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ghrelin ameliorates cognitive dysfunction and neurodegeneration in intrahippocampal amyloid-β1-42 oligomer-injected mice.
    Moon M; Choi JG; Nam DW; Hong HS; Choi YJ; Oh MS; Mook-Jung I
    J Alzheimers Dis; 2011; 23(1):147-59. PubMed ID: 20930280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes.
    David DC; Ittner LM; Gehrig P; Nergenau D; Shepherd C; Halliday G; Götz J
    Proteomics; 2006 Dec; 6(24):6566-77. PubMed ID: 17111439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T-817MA, a neurotrophic agent, ameliorates the deficits in adult neurogenesis and spatial memory in rats infused i.c.v. with amyloid-beta peptide.
    Kimura T; Hong Nguyen PT; Ho SA; Tran AH; Ono T; Nishijo H
    Br J Pharmacol; 2009 Jun; 157(3):451-63. PubMed ID: 19371351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau.
    Tatebayashi Y; Miyasaka T; Chui DH; Akagi T; Mishima K; Iwasaki K; Fujiwara M; Tanemura K; Murayama M; Ishiguro K; Planel E; Sato S; Hashikawa T; Takashima A
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13896-901. PubMed ID: 12368474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transgenic zebrafish model of neurodegeneration.
    Tomasiewicz HG; Flaherty DB; Soria JP; Wood JG
    J Neurosci Res; 2002 Dec; 70(6):734-45. PubMed ID: 12444595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Filamin-A and Myosin VI colocalize with fibrillary Tau protein in Alzheimer's disease and FTDP-17 brains.
    Feuillette S; Deramecourt V; Laquerriere A; Duyckaerts C; Delisle MB; Maurage CA; Blum D; Buée L; Frébourg T; Campion D; Lecourtois M
    Brain Res; 2010 Jul; 1345():182-9. PubMed ID: 20460118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice.
    Kurata T; Miyazaki K; Kozuki M; Panin VL; Morimoto N; Ohta Y; Nagai M; Ikeda Y; Matsuura T; Abe K
    Brain Res; 2011 Jan; 1371():161-70. PubMed ID: 21112317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Riluzole rescues glutamate alterations, cognitive deficits, and tau pathology associated with P301L tau expression.
    Hunsberger HC; Weitzner DS; Rudy CC; Hickman JE; Libell EM; Speer RR; Gerhardt GA; Reed MN
    J Neurochem; 2015 Oct; 135(2):381-94. PubMed ID: 26146790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Animal models of tauopathies].
    Higuchi M
    Rinsho Shinkeigaku; 2006 Nov; 46(11):928-30. PubMed ID: 17432223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy.
    Boekhoorn K; Terwel D; Biemans B; Borghgraef P; Wiegert O; Ramakers GJ; de Vos K; Krugers H; Tomiyama T; Mori H; Joels M; van Leuven F; Lucassen PJ
    J Neurosci; 2006 Mar; 26(13):3514-23. PubMed ID: 16571759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Memory deficits correlate with tau and spine pathology in P301S MAPT transgenic mice.
    Xu H; Rösler TW; Carlsson T; de Andrade A; Bruch J; Höllerhage M; Oertel WH; Höglinger GU
    Neuropathol Appl Neurobiol; 2014 Dec; 40(7):833-43. PubMed ID: 24865638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dietary Lycopene Supplementation Improves Cognitive Performances in Tau Transgenic Mice Expressing P301L Mutation via Inhibiting Oxidative Stress and Tau Hyperphosphorylation.
    Yu L; Wang W; Pang W; Xiao Z; Jiang Y; Hong Y
    J Alzheimers Dis; 2017; 57(2):475-482. PubMed ID: 28269786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
    Zhang Q; Zhang X; Sun A
    Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacological properties of T-817MA, a novel neurotrophic agent, for treatment of Alzheimer's disease.].
    Fukushima T
    Nihon Yakurigaku Zasshi; 2010 Jul; 136(1):11-4. PubMed ID: 20628207
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.